Moderna (DE:0QF)
NASDAQ:0QF
Mrna-1273, Mrna-1283, Mrna-1283.222, Mrna-1273.222, Mrna-1283.815, Mrna-1273.815, Mrna-1283.211, Mrna-1283.529, Mrna-1283.251 Variant-Containing Formulation
Sars-Cov-2
Phase IV
Recruiting
A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without High-Risk Conditions for Severe Coronavirus Disease 2019 (COVID-19)
Nov 25, 2025
Influenza Vaccine, Covid-19 Vaccine, Investigational Influenza Vaccine, Mrna-1083 Composition 1 Dose A Lot A, Mrna-1083 Composition 1 Dose A Lot B, Mrna-1083 Composition 1 Dose B, Mrna-1083 Composition 1 Dose C, Mrna-1083 Composition 2 Dose A, Mrna-1083 Composition 2 Dose B, Mrna-1083 Composition 3 Dose A, Mrna-1083 Composition 3 Dose B, Investigational Covid-19 Vaccine Lot A, Investigational Covid-19 Vaccine Lot B
Influenza, Sars-Cov-2
Phase II
Completed
A Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 (Influenza and COVID-19) Vaccine in Adults ≥18 to <65 Years of Age
Mar 05, 2025
―
Fluarix Tetra, Mrna-1273, Mrna-1083, Licensed Influenza Vaccine, Sars-Cov-2 Vaccine
Influenza, Covid-19
Phase III
Completed
Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 Vaccine (SARS-CoV-2 [COVID-19] and Influenza) in Adults ≥50 Years of Age
Nov 15, 2024
―
Mrna-0184
Healthy Participants
Phase I
Active Not Recruiting
A Study to Investigate Safety and Tolerability of mRNA-0184 Administered Subcutaneously in Healthy Participants
Oct 22, 2024
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Moderna (0QF) have in its pipeline
0QF is currently developing the following drugs: Mrna-1273, Mrna-1283, Mrna-1283.222, Mrna-1273.222, Mrna-1283.815, Mrna-1273.815, Mrna-1283.211, Mrna-1283.529, Mrna-1283.251 Variant-Containing Formulation, Carboplatin, Pembrolizumab, Paclitaxel, Nab-Paclitaxel, Intismeran Autogene, V940, Keytruda, Mrna-4157, Mrna-2808. These drug candidates are in various stages of clinical development as the company works toward FDA approval.